Pharmaceutical manufacturers of Cisplatin

Fresenius Kabi operates as an international healthcare organization specializing in essential medications and advanced technologies for intravenous therapy, blood transfusion, and medical nourishment. The company's portfolio is instrumental in supporting the needs of severely and persistently unwell individuals. Additionally, it provides a variety of active pharmaceutical ingredients (APIs) and finalized goods fabricated within its own establishments

We are one of world’s leading producers of key Active Pharmaceutical Ingredients (APIs) and generic formulations with presence in 140+ countries and backed by 30 years of experience in the pharma sector. We endeavour to serve patients by moulding science and technology into therapies to improve health outcomes and people’s lives.

Established in 1958, Qilu Pharmaceutical is now one of the leading vertically integrated pharmaceutical companies in China that develops, manufactures and distributes both Finished Dosage Forms (FDFs) and Active Pharmaceutical Ingredients (APIs). Qilu currently has 12 subsidiaries, 11 domestic manufacturing sites and over 3,9000 employees worldwide. Qilu ranks among Top 5 in Chinese pharmaceutical industry in 2022. Dedicated to offering high-quality & trustworthy medicines to the world and improving people‘s well-being, Qilu is vigorously exporting its products to over 100 countries and regions around the world.

Fresenius is an international healthcare conglomerate offering products and services for kidney dialysis, hospital care, and home medical treatment. The Fresenius Group comprises four distinct business segments - Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed - each managing its own global operations.

Sicor, situated in the northern region of Italy, is a component of the Teva API business and offers a worldwide platform for the production and promotion of APIs for injectable, inhalation, topical, and nasal products. These specialized facilities possess a significant level of skill, manufacturing approximately 60 active pharmaceutical ingredients.

In just over a decade, Laurus has positioned itself as one of the largest and most innovative API producers globally. Expanding upon its established expertise in chemistry, Laurus has recently adopted full vertical integration, including a strong finished dosage capacity, dedicated capacity for backward integration, and also Synthesis R&D operations in India and the USA.

Veranova boasts over 50 years of expertise and is a frontrunner in the creation and fabrication of intricate and specialized APIs for the pharmaceutical and biotech sectors. It was previously a segment of Johnson Matthey, specializing in intricate and regulated chemical processes. The company delivers customized services throughout all phases of drug development and is split into Generics and Originators. It possesses a variety of development technologies and areas of expertise, along with a cooperative approach to API manufacturing and procedures.

Mac-Chem has a National and Global footprint with a wide presence across the globe. Mac-Chem has carved a niche for itself in the exceedingly competitive and quality conscious sphere of Active Pharmaceutical Ingredients (API) manufacturing with US-FDA, EDQM, COFEPRIS, ANVISA, MFDS-Korea, WHO-GMP and ISO certified facilities

We, at TIEFENBACHER GROUP, are driven by a deep sense of purpose: we are pioneering healthcare to improve patients’ lives around the world. We believe that the access to affordable high quality-healthcare is a human right. We always challenge the status quo to be one step ahead – in terms of business models as well as concrete products and services. This entrepreneurial spirit is the driving force of making high-quality pharmaceuticals more affordable, more available, and better than before. 100% family owned since 1963, we are a purpose-driven healthcare company providing best-in-class solutions throughout the entire pharmaceutical value chain. From initial idea to market access: We distribute raw materials and develop, manufacture, and register finished dosage forms like tablets, capsules, powders, drops, and patches as well as medical devices. This broad competence enables us to pioneer healthcare holistically as we can connect ideas and expertise to create novel healthcare solutions. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-functional structures, we tap into our full potential and stay at the forefront of our field.

Haorui, established in the year 1997, operates as a manufacturer and provider of APIs, pharmaceutical intermediates, veterinary products, and food additives. Furthermore, it aids international pharmaceutical firms in achieving domestic registration for their finished dosage forms to support their global expansion efforts. The company's array of USFDA approved products includes Flumazenil, Granisetron HCl, Granisetron Base, Docetaxel Anhydrous, Irinotecan HCl, and Dasatinib Monohydrate among others. Its headquarters is situated in Shenzhen, China, while it maintains four manufacturing sites in Hubei, Zhejiang, Jiangxi, and Henan. The Hubei facility is recognized for its USFDA and EU GMP approvals, specializing in the production of high potency and oncology materials within a dedicated oncology workshop, meeting OEB 5 material production standards. Haorui prides itself as a dependable partner for all your pharmaceutical needs.

Hubei Haosun Pharmaceutical Co.,Ltd. produces and sells drugs. The Company manufactures and sells irinotecan hydrochloride, docetaxel anhydrous, dasatinib monohydrate, flumazenil, and other products. Hubei Haosun Pharmaceutical markets its products primarily throughout China with limited overseas

Heraeus is a family-owned global technology group headquartered in Hanau, Germany. The company’s roots go back to a family pharmacy started in 1660. With its expertise and resources, Heraeus has been making meaningful contributions over generations and is committed to do so in the future. Today, the group bundles diverse activities in four Business Platforms: Metals and Recycling, Healthcare, Semiconductor and Electronics, as well as Industrials. Customers benefit from innovative technologies and solutions based on broad materials knowledge and technological leadership.

SMPL, a prominent pharmaceutical wholesaler, distributor, exporter, and manufacturer in India, specializes in a comprehensive range of speciality medicines such as Oncology, Neurology, Cardiology, Anti-Virals, Hepatitis, Antifungals, injections, life saving medicines, and vaccines. The company operates temperature-controlled warehouses in multiple locations in India and Africa, leveraging over 10 years of global supply expertise and a team of 25+ employees. Exporting to over 23 countries across EU, MENA, African, and South East Asia, SMPL is a government recognized ISO 9001:2015, GDP certified pharmaceutical company committed to providing authentic products and services worldwide. Visit our stall for more information!

Ascensus Specialties LLC, with its headquarters in Bellevue, Washington, USA, is a dominant player in borohydride, borane, and specialty alcoholate reagents, CVD/ALD precursors, and high-purity APIs and cGMP materials globally. The company's chemistries enhance the manufacturing processes for its clients, making them more streamlined, safer, and more precise. The Strem Catalog, a part of their offerings, supplies high-purity materials for research purposes, fostering innovation. The company operates top-tier production facilities in Elma, Washington, Evans City, Pennsylvania, and Newburyport, Massachusetts. Ascensus Specialties is capable of meeting the increasing worldwide demand for premium Sodium Borohydride, reactive and alkali metals, boranes, CVD & ALD precursors, and other specialized chemicals. The company maintains three ISO-certified sites in the United States—a hydroelectric facility in Washington state with minimal waste, a Pennsylvania plant with over 80 years of operational experience, and a Massachusetts facility specializing in laboratory, high-pressure, and cGMP manufacturing—all boasting exemplary safety records.

Strem established in 1964, is a company that manufactures and markets specialty chemicals of high purity. Strem was acquired by Ascensus Specialties in 2021. Its clients include academic, industrial and government research and development laboratories as well as commercial scale businesses in the pharmaceutical, microelectronic and chemical / petrochemical industries. Strem also provides custom synthesis (including high pressure synthesis) and cGMP manufacturing services.